Catheterization Lab Equipment in Kansas

Worldwide Innovations & Technologies, Inc. (WIT) is a Kansas-based manufacturer of lead-free, disposable radiation protection products designed for medical personnel and patients in high-exposure clinical environments. Founded in 1992, WIT specializes in RADPAD® radiation shielding systems—clinically proven, disposable drapes and protective barriers that reduce scatter radiation exposure in interventional and diagnostic imaging procedures. Products are ISO 13485 certified and CE marked, supporting ALARA (As Low As Reasonably Achievable) compliance. RADPAD solutions are deployed in over 2,000 hospitals worldwide across cardiac catheterization laboratories, electrophysiology labs, endovascular surgery suites, and interventional radiology departments. The company provides clinical education, radiation dose evaluation, and training support to help medical teams optimize occupational radiation safety and protect long-term health.

Medical Positioning, Inc., founded in 1988 and headquartered in Lenexa, Kansas, manufactures specialized positioning and examination tables for diagnostic imaging and cardiology procedures. The company designs ergonomic equipment supporting echocardiography, cardiac catheterization, ultrasound imaging, mammography, modified barium swallow studies, and stress testing. Core product lines include the EchoBed® series (EchoBed® X, Stress EchoBed®), UltraScan® Versa™ tables for general and gynecological ultrasound, VasScan Table™ X for vascular imaging, UltraMamm® for mammography and breast ultrasound, MultiView® Modified Barium Swallow Chair, and tilt tables (HUT®, RR HUT®) for syncope and bradycardia evaluation. The Cath Ergometer™ supports right heart catheterization procedures. Additional offerings include the GSPM™ Table for pain management and C-arm imaging, Ultra DBI™ and stereotactic breast biopsy tables, and the EchoTable™. Medical Positioning serves hospitals, imaging centers, research facilities, medical schools, and distributors nationally and internationally. Products are engineered for clinical precision and operator comfort, with specialized positioning capabilities for specific diagnostic protocols. The company maintains direct sales and support operations in the United States.

EnsiteVascular is a specialized medical device manufacturer focused exclusively on vascular closure solutions for catheter-based cardiovascular procedures. The company develops and markets the SITESEAL® and SITESEAL SV™ device families—FDA-cleared, non-implant vascular closure devices designed for electrophysiology (EP), interventional cardiology, and structural heart procedures. SITESEAL® is engineered for arterial and venous access closure across all sheath sizes, including large-bore interventions (EVAR, TEVAR, TAVI), offering hemostasis without leaving foreign material behind. Key differentiators include no sheath size limitations, closure of multiple sheaths in a single vessel, rapid hemostasis (typically under 5 minutes), immediate patient mobility, and reduced access-site complications. Clinical data demonstrates zero hematomas or delayed bleeding in a 138-patient comparative study versus suture-based and collagen-plug competitors. The device improves cath lab workflow efficiency, reduces procedure-related costs per access site, and enhances patient comfort and ambulation recovery. SITESEAL® targets high-volume hospital catheterization labs, ambulatory surgery centers, and EP procedure centers across the United States, competing in the $1.4 billion annual vascular closure market.